UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Angewandte Chemie (International ed.), 2013-02, Vol.52 (7), p.2060-2062

International ed. in English, 2013

Volltextzugriff (PDF)

7-(4 H-1,2,4-Triazol-3-yl)benzo[ c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity

Bioorganic & medicinal chemistry letters, 2011-11, Vol.21 (22), p.6687-6692

2011

Volltextzugriff (PDF)

Potent, Orally Active Corticotropin-Releasing Factor Receptor-1 Antagonists Containing a Tricyclic Pyrrolopyridine or Pyrazolopyridine Core

Journal of medicinal chemistry, 2005-06, Vol.48 (12), p.4100-4110

2005

Volltextzugriff (PDF)

Corrigendum: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Angewandte Chemie (International ed.), 2013-11, Vol.52 (46), p.11963-11963

International ed. in English, 2013

Volltextzugriff (PDF)

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3327-3331

2012

Volltextzugriff (PDF)

Se ‐Phenyl Prop‐2‐eneselenoate: An Ethylene Equivalent for Diels–Alder Reactions

Angewandte Chemie, 2013-02, Vol.125 (7), p.2114-2116

2013

Volltextzugriff (PDF)

Synthesis and SAR of inhibitors of protein kinase CK2: Novel tricyclic quinoline analogs

Bioorganic & medicinal chemistry letters, 2012-01, Vol.22 (1), p.45-48

2012

Volltextzugriff (PDF)

A Facile Synthesis of 5-Halopyrimidine-4-Carboxylic Acid Esters via a Minisci Reaction

Synlett, 2012-02, Vol.23 (3), p.443-447

2012

Volltextzugriff (PDF)

Structure–activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists

Bioorganic & medicinal chemistry letters, 2005-08, Vol.15 (16), p.3685-3690

2005

Volltextzugriff (PDF)

Berichtigung: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Angewandte Chemie, 2013-11, Vol.125 (46), p.12181

2013

Volltextzugriff (PDF)

ChemInform Abstract: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

ChemInform, 2013-07, Vol.44 (30), p.no-no

2013

Volltextzugriff (PDF)

Berichtigung: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Angewandte Chemie, 2013-11, Vol.125 (46), p.12181-12181

2013

Volltextzugriff (PDF)

ChemInform Abstract: A Facile Synthesis of 5-Halopyridine-4-carboxylic Acid Esters via a Minisci Reaction

ChemInform, 2012-06, Vol.43 (23), p.no-no

2012

Volltextzugriff (PDF)

Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Angewandte Chemie, 2013-02, Vol.125 (7), p.2114-2116

2013

Volltextzugriff (PDF)

Structure-activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists: G-protein-coupled receptors in drug discovery

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (16), p.3685-3690

2005

Volltextzugriff (PDF)

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

The New England journal of medicine, 2021-09, Vol.385 (13), p.1172-1183

2021

Volltextzugriff (PDF)

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

The lancet oncology, 2011-11, Vol.12 (12), p.1101-1108

2011

Volltextzugriff (PDF)

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

The New England journal of medicine, 2009-08, Vol.361 (8), p.766-776

2009

Volltextzugriff (PDF)

Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist

Organic & biomolecular chemistry, 2019-01, Vol.17 (5), p.1225-1237

2019

Volltextzugriff (PDF)

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants

Genetics in medicine, 2022-01, Vol.24 (1), p.130-145

2022

Volltextzugriff (PDF)

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Breast cancer research : BCR, 2011-05, Vol.13 (3), p.209-209, Article 209

2011

Volltextzugriff (PDF)

FRI538 Discovery And Characterization Of Orally Bioavailable Nonpeptide Thyroid Stimulating Hormone Receptor (TSHR) Antagonists For The Treatment Of Graves’ Disease

Journal of the Endocrine Society, 2023-10, Vol.7 (Supplement_1)

2023

Volltextzugriff (PDF)

Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial: Trials

Trials, 2019-01, Vol.20 (1)

2019

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

7-(4 H-1,2,4-Triazol-3-yl)benzo[ c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity

Potent, Orally Active Corticotropin-Releasing Factor Receptor-1 Antagonists Containing a Tricyclic Pyrrolopyridine or Pyrazolopyridine Core

Corrigendum: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells

Se ‐Phenyl Prop‐2‐eneselenoate: An Ethylene Equivalent for Diels–Alder Reactions

Synthesis and SAR of inhibitors of protein kinase CK2: Novel tricyclic quinoline analogs

A Facile Synthesis of 5-Halopyrimidine-4-Carboxylic Acid Esters via a Minisci Reaction

Structure–activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists

Berichtigung: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

ChemInform Abstract: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Berichtigung: Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

ChemInform Abstract: A Facile Synthesis of 5-Halopyridine-4-carboxylic Acid Esters via a Minisci Reaction

Se-Phenyl Prop-2-eneselenoate: An Ethylene Equivalent for Diels-Alder Reactions

Structure-activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists: G-protein-coupled receptors in drug discovery

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

FRI538 Discovery And Characterization Of Orally Bioavailable Nonpeptide Thyroid Stimulating Hormone Receptor (TSHR) Antagonists For The Treatment Of Graves’ Disease

Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial: Trials

Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonistElectronic supplementary information (ESI) available. See DOI: 10.1039/C8OB02982B

Suchergebnisse filtern